Study protocol: Phase 2 trial of re-treatment with 177Lu-PSMA-617 molecular radiotherapy for metastatic castration resistant prostate cancer (RE-LuPSMA trial). Previously presented at ESMO 2024, FPN: ...
The idea for the Hub first came from Huntington Mayor Patrick Farrell soon after taking office in January. He said Tuesday during an appearance on MetroNews Midday he remembers how cold it was and he ...
Terns Pharmaceuticals announced significant updates regarding TERN-601, a novel oral GLP-1R agonist, following a successful Phase 1 clinical study and the completion of enrollment in its Phase 2 ...
Kymera Therapeutics, Inc. (KYMR) just reported positive results from its phase 1 healthy volunteer study using KT-621. The purpose of this clinical candidate is to develop it as an oral STAT6 protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results